Established in 2015, Sichuan Chenghua Bio-technology manufactures specialty pharmaceutical intermediates and APIs, including midostaurin, cenicriviroc, taxane-related intermediates (a 10-DAB III derivative), and bile-acid chemistry such as chenodeoxycholic acid derivatives and an isavuconazole intermediate. Hosting the Academician Chen Xinzi Innovation Team technology transfer project in Wenjiang Medical City, the company offers CMO contract manufacturing, accepts buyer-specified requirements and small orders, and supports LC, DA, and TT payment terms across markets in Asia, the Middle East, and beyond.


![4-Chloro-Benzenesulfonic Acid 5-(2,4-Difluoro-Phenyl)-5-[1,2,4]Triazol-1-YlMethyl-Tetrahydro-Furan-3](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F4-chloro-benzenesulfonic-acid-5-24-diflu-167150.jpg&w=640&q=75)
![Glycine,N-[(1,1-DiMethylethoxy)Carbonyl]-N-Methyl-,[2-[[(1-Chloroethoxy)Carbonyl]MethylaMino]-3-Pyri](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fglycinen-11-dimethylethoxycarbonyl-n-met-167146.jpg&w=640&q=75)
![Sulfuric Acid Mono-[7-Oxo-2-(Piperidin-4-YlcarbaMoyl)-1,6-Diaza-Bicyclo[3.2.1]Oct-6-Yl] Este](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fsulfuric-acid-mono-7-oxo-2-piperidin-4-y-167158.jpg&w=640&q=75)
No comments available.
Leave your rating & comment